Recombinant_interferon-gamma_(rIFN-gamma)_in_dermatology._This_paper_gives_a_short_review_on_the_function,_pharmacokinetics,_and_therapeutic_application_of_recombinant_interferon-gamma_(rIFN-gamma)_in_dermatology._Simultaneously,_our_own_experiences_are_presented_for_57_patients_(phase_II_study)_suffering_from_genital_warts_(21_patients),_psoriatic_arthritis_(10_patients),_psoriasis_vulgaris_(three_patients),_malignant_melanoma_(six_patients),_bowenoid_papulosis_(four_patients),_Behcet's_disease_(four_patients),_basal_cell_carcinoma_(six_patients),_as_well_as_herpes_simplex_recidivans,_epidermodysplasia_verruciformis,_and_mycosis_fungoides_(one_patient_each)._We_conclude_that_there_might_be_an_indication_for_treatment_with_rIFN-gamma_in_genital_warts,_bowenoid_papulosis,_Behcet's_disease,_and_microbial_infections,_such_as_leprosy_and_cutaneous_leishmaniasis._Even_though_there_are_reports_of_a_limited_beneficial_effect_of_rIFN-gamma_on_arthritis_and_skin_lesions_in_psoriasis,_we_failed_to_observe_any_in_10_patients._The_main_side_effects_in_our_low-dose_study_(50-100_micrograms/d)_were_mild_fever_(78%),_fatigue_(78%),_and_myalgia_(65%)._Laboratory_tests_revealed_an_increase_in_the_serum_triglyceride_level,_in_particular,_in_psoriatic_patients.